About: covid:4b87f5659fc6fe12a680aedc65c104806cfda193

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:4b87f5659fc6fe12a680aedc65c104806cfda193 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Gören, Tarık Kurt, Özgür Köseler, Aylin Palmeira, Andreia Pinto, Madalena Sabirli, Ramazan Sousa, Emília Türkçüer, Ibrahim Vasconcelos, M
is schema:about of	named entity 'SARS-CoV-2' named entity 'studies' named entity 'inhibitors' named entity 'cell' named entity 'target' named entity 'binding domain' named entity 'surface' named entity 'evidence' named entity 'TARGETS' named entity 'STUDIES' named entity '10%' named entity 'SMALL MOLECULES' named entity 'DRUGBANK' named entity 'HOST CELL SURFACE' covid:arg/4b87f5659fc6fe12a680aedc65c104806cfda193 named entity 'antiviral' named entity 'activity' named entity 'addition' named entity 'addition' named entity 'GRP78' named entity 'ATP' named entity 'cell surface' named entity 'ARDS' named entity 'molecular docking' named entity 'patients' named entity 'gene' named entity 'molecular' named entity 'targets' named entity 'total' named entity 'GRP78' named entity 'SARS-CoV-2' named entity 'structure-based' named entity 'GRP78' named entity 'DrugBank' named entity 'Gene expression studies' named entity 'pneumonia' named entity 'SARS-CoV-2' named entity 'molecular docking' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'nucleotide' named entity 'molecular target' named entity 'mRNA' named entity 'pneumonia' named entity 'SARS-CoV-2' named entity 'gene expression' named entity 'DrugBank' named entity 'kcal' named entity 'GRP78' named entity 'approved drugs' named entity 'Coxsackievirus' named entity 'force field' named entity 'SRC' named entity 'endothelial' named entity 'NBD' named entity 'molecular target' named entity 'pneumonia' named entity 'assay' named entity 'Applied Biosystems' named entity 'Cell surface' named entity 'high-throughput screen' named entity 'free energy of binding' named entity 'Foster City' named entity 'vital parameters' named entity 'SARS-CoV-2' named entity 'ovine' named entity 'structure-based' named entity 'FDA' named entity 'ACE2 receptor' named entity 'molecule' named entity 'Severe Acute Respiratory Syndrome' named entity 'SARS-CoV-2' named entity 'Bosutinib' named entity 'Covid' named entity 'SARS-CoV-2' named entity 'conformation' named entity 'virus replication' named entity 'diastolic blood pressure' named entity 'infection' named entity 'Spike protein' named entity 'Virtual screening' named entity 'CCG' named entity 'CURB-65' named entity 'infection' named entity 'virions' named entity 'molecular chaperone' named entity 'GRP78' named entity 'Cell surface' named entity 'VER' named entity 'HSPA5'

Attributes

Values

Creator

Gören, Tarık
Kurt, Özgür
Köseler, Aylin
Palmeira, Andreia
Pinto, Madalena
Sabirli, Ramazan
Sousa, Emília
Türkçüer, Ibrahim
Vasconcelos, M

is schema:about of

named entity 'SARS-CoV-2'
named entity 'studies'
named entity 'inhibitors'
named entity 'cell'
named entity 'target'
named entity 'binding domain'
named entity 'surface'
named entity 'evidence'
named entity 'TARGETS'
named entity 'STUDIES'
named entity '10%'
named entity 'SMALL MOLECULES'
named entity 'DRUGBANK'
named entity 'HOST CELL SURFACE'
covid:arg/4b87f5659fc6fe12a680aedc65c104806cfda193
named entity 'antiviral'
named entity 'activity'
named entity 'addition'
named entity 'addition'
named entity 'GRP78'
named entity 'ATP'
named entity 'cell surface'
named entity 'ARDS'
named entity 'molecular docking'
named entity 'patients'
named entity 'gene'
named entity 'molecular'
named entity 'targets'
named entity 'total'
named entity 'GRP78'
named entity 'SARS-CoV-2'
named entity 'structure-based'
named entity 'GRP78'
named entity 'DrugBank'
named entity 'Gene expression studies'
named entity 'pneumonia'
named entity 'SARS-CoV-2'
named entity 'molecular docking'
named entity 'SARS-CoV-2'
named entity 'SARS-CoV-2'
named entity 'SARS-CoV-2'
named entity 'nucleotide'
named entity 'molecular target'
named entity 'mRNA'
named entity 'pneumonia'
named entity 'SARS-CoV-2'
named entity 'gene expression'
named entity 'DrugBank'
named entity 'kcal'
named entity 'GRP78'
named entity 'approved drugs'
named entity 'Coxsackievirus'
named entity 'force field'
named entity 'SRC'
named entity 'endothelial'
named entity 'NBD'
named entity 'molecular target'
named entity 'pneumonia'
named entity 'assay'
named entity 'Applied Biosystems'
named entity 'Cell surface'
named entity 'high-throughput screen'
named entity 'free energy of binding'
named entity 'Foster City'
named entity 'vital parameters'
named entity 'SARS-CoV-2'
named entity 'ovine'
named entity 'structure-based'
named entity 'FDA'
named entity 'ACE2 receptor'
named entity 'molecule'
named entity 'Severe Acute Respiratory Syndrome'
named entity 'SARS-CoV-2'
named entity 'Bosutinib'
named entity 'Covid'
named entity 'SARS-CoV-2'
named entity 'conformation'
named entity 'virus replication'
named entity 'diastolic blood pressure'
named entity 'infection'
named entity 'Spike protein'
named entity 'Virtual screening'
named entity 'CCG'
named entity 'CURB-65'
named entity 'infection'
named entity 'virions'
named entity 'molecular chaperone'
named entity 'GRP78'
named entity 'Cell surface'
named entity 'VER'
named entity 'HSPA5'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software